Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Journal of veterinary internal medicine in 2026 evaluated serum pancreatitis-associated protein 1 concentrations in dogs with acute signs of gastrointestinal disease and normal or abnormal DGGR lipase activity..
Key Findings
Pancreatitis-associated protein (PAP-1) is synthesized during acute pancreatitis (AP) and chronic enteropathy in people. Serum PAP-1 concentration (PAP-1) has not been measured prospectively in dogs. Evaluate whether PAP-1 differentiates suspected AP (sAP) diagnosed by abnormal DGGR-lipase activity from non-pancreatic acute gastrointestinal disease (aGId) diagnosed by normal DGGR-lipase activity. Twenty-six dogs with sAP, 48 dogs with aGId based on signs of acute gastrointestinal disease, lipase activity > 450 U/L (reference interval [RI],17-156 U/L) and maximally 20 U/L > RI, respectively. Forty healthy control dogs. Prospective daily...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
List
Add
Please enter a comment